+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits



Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits



Journal of Clinical Virology 36(2): 126-132



Infection with human papillomavirus (HPV) is a necessary step in the progression to cervical cancer. Many methods for HPV testing are currently available, most developed to detect pools of HPV types. To evaluate the HPV typing by molecular methods and to compare commercial kits with an established laboratory method. Eighty-four cervical samples found to be positive for HPV DNA by GP5+/6+-polymerase chain reaction-enzyme immunoassay-reverse line blotting (PCR-EIA-RLB) were re-tested with two commercial methods, INNO-LiPA and Amplisense HPV typing, able to identify the HPV type predicted by PCR-EIA-RLB in 76 and 67 samples, respectively. The INNO-LiPA assay revealed HPV DNA in 75/76 samples (98.7%; 95% CI, 0.93-0.99) that would contain HPV types identifiable by this assay. The Amplisense HPV assay revealed HPV DNA in 58/67 samples (86.6%; 95% CI, 0.76-0.93) containing HPV types detectable by this assay. For samples with a single infection, the unweighted kappa for concordance of HPV typing was 0.87 (95% CI, 0.78-0.97) for PCR-EIA-RLB versus INNO-LiPA, 0.94 (95% CI, 0.87-0.99) for INNO-LiPA versus Amplisense HPV, and 0.82 (95% CI, 0.70-0.94) for PCR-EIA-RLB versus Amplisense HPV typing. PCR-EIA-RLB revealed 12 multiple infections, INNO-LiPA revealed 14, and Amplisense HPV revealed 5. The agreement among tests for samples with multiple infections was lower, giving kappa values of 0.44 (95% CI, 0.18-0.70) for PCR-EIA-RLB versus INNO-LiPA, 0.52 (95% CI, 0.19-0.85) for PCR-EIA-RLB versus Amplisense HPV and 0.43 (95% CI, 0.12-0.74) for INNO-LiPA versus Amplisense HPV. In HPV-positive samples, the agreement among tests for HPV typing was high for single infections but markedly lower for infections with multiple HPV types.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049253393

Download citation: RISBibTeXText

PMID: 16624614

DOI: 10.1016/j.jcv.2006.03.002


Related references

Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. Journal of Clinical Virology 42(4): 361-367, 2008

Comparison of real-time reverse transcriptase-polymerase chain reaction and nested or commercial reverse transcriptase-polymerase chain reaction for the detection of hepatitis E virus particle in human serum (vol 56, pg 269, 2006). Diagnostic Microbiology and Infectious Disease 57(3): 353, 2007

Comparison of real-time reverse transcriptase-polymerase chain reaction and nested or commercial reverse transcriptase-polymerase chain reaction for the detection of hepatitis E virus particle in human serum. Diagnostic Microbiology and Infectious Disease 56(3): 269-274, 2006

Analysis of human papillomavirus type 16 E6/E7 mRNA in cervical cancers and precancerous lesions by means of the polymerase chain reaction with reverse transcriptase reaction. Nihon Sanka Fujinka Gakkai Zasshi 43(12): 1660-1666, 1991

Species-specific detection of Legionella using polymerase chain reaction and reverse dot-blotting. FEMS Microbiology Letters 140(2-3): 111-119, 1996

Type specific detection of human papillomavirus dna using the polymerase chain reaction. Laboratory Investigation 60(1): 107A, 1989

Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identification of human papillomavirus type 16 variants. Journal of Clinical Virology 51(3): 165-169, 2011

Detection of human papillomavirus types 45 and 51 by type-specific polymerase chain reaction. Journal of Virological Methods 146(1-2): 405-408, 2007

Detection of human immunodeficiency virus type 2 by real time reverse transcriptase polymerase chain reaction and nested reverse transcriptase polymerase chain reaction. 2007

Type specific detection of human papillomavirus dna in anogenital carcinomas using the polymerase chain reaction. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 31: 156, 1991

Comparative analysis of human papillomavirus detection by polymerase chain reaction and Virapap/Viratype kits. American Journal of Clinical Pathology 94(5): 554-560, 1990

Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. American Journal of Pathology 155(5): 1473-1478, 1999

The polymerase chain reaction for human papillomavirus detection and typing. Oral Surgery Oral Medicine Oral Pathology 70(5): 612, 1990

Detection of human papillomavirus type 16 mRNA in cervical intraepithelial neoplasia with an anti-E4 antibody Correlation with reverse-transcriptase nested-polymerase chain reaction. Pathology Research & Practice 196(6): 381, 2000

Use of universal and type-specific primers in the polymerase chain reaction for the detection and typing of genital human papillomaviruses. Japanese Journal of Cancer Research 82(4): 411-419, 1991